Perforin-independent Beta-cell Destruction by Diabetogenic CD8(+) T Lymphocytes in Transgenic Nonobese Diabetic Mice

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1999 Apr 20

PMID 10207172

Citations 31

Authors

A Amrani

J Verdaguer

B Anderson

T Utsugi

S Bou

P Santamaria

Affiliations

Soon will be listed here.

Abstract

Autoimmune diabetes in nonobese diabetic (NOD) mice results from destruction of pancreatic beta cells by T lymphocytes. It is believed that CD8(+) cytotoxic T lymphocytes (CTLs) effect the initial beta-cell insult in diabetes, but the mechanisms remain unclear. Studies of NOD.lpr mice have suggested that disease initiation is a Fas-dependent process, yet perforin-deficient NOD mice rarely develop diabetes despite expressing Fas. Here, we have investigated the role of perforin and Fas in the ability of beta cell-reactive CD8(+) T cells bearing a T-cell receptor (8.3-TCR) that is representative of TCRs used by CD8(+) CTLs propagated from the earliest insulitic lesions of NOD mice, and that targets an immunodominant peptide/H-2Kd complex on beta cells, to effect beta-cell damage in vitro and in vivo. In vitro, 8.3-CTLs killed antigenic peptide-pulsed non-beta-cell targets via both perforin and Fas, but they killed NOD beta cells via Fas exclusively. Perforin-deficient 8.3-TCR-transgenic NOD mice expressing an oligoclonal or monoclonal T-cell repertoire developed diabetes even more frequently than their perforin-competent littermates. These results demonstrate that diabetogenic CD8(+) CTLs representative of CTLs putatively involved in the initiation of autoimmune diabetes kill beta cells in a Fas-dependent and perforin-independent manner.

Citing Articles

Pancreatic Islet Cells Response to IFNγ Relies on Their Spatial Location within an Islet.

De Burghgrave M, Lourenco C, Berthault C, Aiello V, Villalba A, Fouque A Cells. 2023; 12(1).

PMID: 36611907 PMC: 9818682. DOI: 10.3390/cells12010113.

Understanding the Effects of Age and T-Cell Differentiation on COVID-19 Severity: Implicating a Fas/FasL-mediated Feed-Forward Controller of T-Cell Differentiation.

Leonardi A, Argyropoulos C, Hamdy A, Proenca R Front Immunol. 2022; 13:853606.

PMID: 35309371 PMC: 8927653. DOI: 10.3389/fimmu.2022.853606.

Beta Cell Therapies for Preventing Type 1 Diabetes: From Bench to Bedside.

Brawerman G, Thompson P Biomolecules. 2020; 10(12).

PMID: 33339173 PMC: 7765619. DOI: 10.3390/biom10121681.

Soluble FAS ligand is not required for pancreatic islet inflammation or beta-cell destruction in non-obese diabetic mice.

Trivedi P, Fynch S, Kennedy L, Chee J, Krishnamurthy B, OReilly L Cell Death Discov. 2019; 5:136.

PMID: 31552143 PMC: 6755132. DOI: 10.1038/s41420-019-0217-z.

Mitochondrial Reactive Oxygen Species and Type 1 Diabetes.

Chen J, Stimpson S, Fernandez-Bueno G, Mathews C Antioxid Redox Signal. 2018; 29(14):1361-1372.

PMID: 29295631 PMC: 6166689. DOI: 10.1089/ars.2017.7346.

References

Reich E, Sherwin R, Kanagawa O, Janeway Jr C . An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature. 1989; 341(6240):326-8. DOI: 10.1038/341326a0. View

DiLorenzo T, Graser R, Ono T, Christianson G, Chapman H, Roopenian D . Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement. Proc Natl Acad Sci U S A. 1998; 95(21):12538-43. PMC: 22866. DOI: 10.1073/pnas.95.21.12538. View

Bendelac A, Carnaud C, Boitard C, Bach J . Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. J Exp Med. 1987; 166(4):823-32. PMC: 2188705. DOI: 10.1084/jem.166.4.823. View

Miller B, Appel M, ONeil J, Wicker L . Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol. 1988; 140(1):52-8. View

Muller C, Kagi D, Aebischer T, Odermatt B, HELD W, Podack E . Detection of perforin and granzyme A mRNA in infiltrating cells during infection of mice with lymphocytic choriomeningitis virus. Eur J Immunol. 1989; 19(7):1253-9. DOI: 10.1002/eji.1830190716. View

Ohashi P, Oehen S, BUERKI K, Pircher H, Ohashi C, Odermatt B . Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 1991; 65(2):305-17. DOI: 10.1016/0092-8674(91)90164-t. View

Nakano N, Kikutani H, Nishimoto H, Kishimoto T . T cell receptor V gene usage of islet beta cell-reactive T cells is not restricted in non-obese diabetic mice. J Exp Med. 1991; 173(5):1091-7. PMC: 2118862. DOI: 10.1084/jem.173.5.1091. View

Yagi H, Matsumoto M, Kunimoto K, Kawaguchi J, Makino S, Harada M . Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. Eur J Immunol. 1992; 22(9):2387-93. DOI: 10.1002/eji.1830220931. View

Bradley B, Haskins K, La Rosa F, Lafferty K . CD8 T cells are not required for islet destruction induced by a CD4+ islet-specific T-cell clone. Diabetes. 1992; 41(12):1603-8. DOI: 10.2337/diab.41.12.1603. View

10.

Christianson S, Shultz L, Leiter E . Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes. 1993; 42(1):44-55. DOI: 10.2337/diab.42.1.44. View

11.

Wallny H, Deres K, Faath S, Jung G, Van Pel A, Boon T . Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant. Int Immunol. 1992; 4(10):1085-90. DOI: 10.1093/intimm/4.10.1085. View

12.

Leithauser F, Dhein J, Mechtersheimer G, Koretz K, Bruderlein S, Henne C . Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest. 1993; 69(4):415-29. View

13.

Katz J, Benoist C, Mathis D . Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur J Immunol. 1993; 23(12):3358-60. DOI: 10.1002/eji.1830231244. View

14.

Wicker L, Leiter E, Todd J, Renjilian R, Peterson E, FISCHER P . Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes. 1994; 43(3):500-4. DOI: 10.2337/diab.43.3.500. View

15.

Serreze D, Leiter E, Christianson G, Greiner D, Roopenian D . Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes. 1994; 43(3):505-9. DOI: 10.2337/diab.43.3.505. View

16.

Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen K . Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 1994; 369(6475):31-7. DOI: 10.1038/369031a0. View

17.

Hanabuchi S, Koyanagi M, Kawasaki A, Shinohara N, Matsuzawa A, Nishimura Y . Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc Natl Acad Sci U S A. 1994; 91(11):4930-4. PMC: 43903. DOI: 10.1073/pnas.91.11.4930. View

18.

Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S . Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science. 1994; 265(5171):528-30. DOI: 10.1126/science.7518614. View

19.

Walsh C, Matloubian M, Liu C, Ueda R, Kurahara C, Christensen J . Immune function in mice lacking the perforin gene. Proc Natl Acad Sci U S A. 1994; 91(23):10854-8. PMC: 45124. DOI: 10.1073/pnas.91.23.10854. View

20.

Lowin B, Beermann F, Schmidt A, Tschopp J . A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proc Natl Acad Sci U S A. 1994; 91(24):11571-5. PMC: 45273. DOI: 10.1073/pnas.91.24.11571. View